T2 Biosystems CS (TTOO)

$0.08 -0.06 (-41.49%)
Market Cap 4.09M
Revenue (ttm) 7.19M
Net Income (ttm) -50.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -696.52%
Debt to Equity Ratio 0.00
Volume 4,010,500
Avg Vol 1,494,488
Day's Range N/A - N/A
Shares Out 21.04M
Stochastic %K 5%
Beta 0.35
Analysts Hold
Price Target $5.00

Company Profile

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 761 4646
Address:
101 Hartwell Avenue, Lexington, United States
Fair_Trader42
Fair_Trader42 Jan. 25 at 4:43 AM
$TTOO This new Sepsis Care Act.. The Act’s focus on standardizing sepsis care and incentivizing performance improvements will push hospitals toward technologies that reduce time to diagnosis and improve outcomes. As hospitals are measured and potentially rewarded on sepsis outcomes, technologies that shift antibiotic therapy and more accurately will become more attractive. They reward performance, and rapid diagnostics meet those metrics. The Act creates system-level incentives where T2Dx excels. The $20 million is a policy lever that: • pushes hospitals to prioritize quality sepsis care, • encourages adoption of better diagnostics, and • strengthens the climate for technologies like T2Dx. In other words: this is a direct and meaningful tailwind for the clinical adoption thesis around rapid sepsis diagnostics!
0 · Reply
bud1234
bud1234 Jan. 25 at 1:38 AM
$TTOO why did t2 biosystems name their technology T2MR when radiology already has a MRI Scanner that is referenced as T2MR? T2 Biosystems named their technology T2MR because the term is a precise technical description of the specific physical principle their device measures: the T2 relaxation time of water molecules in a magnetic field. The overlap with the radiology term "T2MR" (referring to T2-weighted MRI) is due to both technologies being based on the exact same underlying physics principle, but applied in different contexts. The Rationale for the Name Shared Scientific Principle: Both the T2 Biosystems instrument and a conventional MRI scanner operate using magnetic resonance technology. They both rely on measuring how hydrogen protons in water molecules react in the presence of a magnetic field and the subsequent signal they produce as they "relax".
1 · Reply
bud1234
bud1234 Jan. 25 at 1:17 AM
$TTOO Correction... again apologizes... can radiopharmaceuticals assist T2Dx instrument in diagnostics No, radiopharmaceuticals do not assist the T2Dx® Instrument in diagnostics; the two technologies operate on entirely separate physical and biological principles and are used in different diagnostic fields. Radiopharmaceuticals vs. the T2Dx Instrument Radiopharmaceuticals are used for in vivo imaging (inside the body) via nuclear medicine scans (PET or SPECT). They detect metabolic or functional activity by emitting radiation, which the scanner captures to create an image of the body. The T2Dx Instrument is an in vitro laboratory diagnostic device. It analyzes a patient's whole blood sample using T2 magnetic resonance (T2MR) technology to rapidly detect the DNA of specific sepsis-causing pathogens (bacteria and fungi).
0 · Reply
bud1234
bud1234 Jan. 25 at 1:01 AM
$TTOO please note T2MR referenced in my post below is not connected to T2 Biosystems. .. a T2MR scanner is not the same as the T2MR instrument that test blood for sepsis? A large whole-body T2MR scanner is used in radiology for anatomical imaging apologize for the misunderstanding and mis direction..
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 25 at 12:10 AM
$TTOO https://www.sepsis.org/news/sepsis-alliance-congratulates-house-leaders-on-introduction-of-the-sepsis-act/
0 · Reply
bud1234
bud1234 Jan. 24 at 9:38 PM
$TTOO Jan 23 2026 Seeking Alpha article: CAH Position In Radiopharmaceuticals https://seekingalpha.com/article/4862216-cardinal-health-upgraded-maintains-investment-grade-status-and-positioning-in-radiopharmaceuticals
1 · Reply
bud1234
bud1234 Jan. 24 at 9:32 PM
$TTOO ai info, DD req'd ( AI can make mistakes so verify) Possible future CAH/ T2MR Technology collaboration?? Cardinal Health has spent more than $50 million in the past three years on the plant, named the Center for Theranostics (a combination of “therapeutics” and “diagnostics”) Radiopharmaceuticals work with T2 Magnetic Resonance (T2MR) diagnostics by offering functional/molecular information via nuclear imaging (PET or SPECT), which is then combined with the anatomical/structural details and T2 relaxation data from an MRI to provide a more complete clinical picture. This integrated approach is often referred to as theranostics or hybrid imaging (e.g., a PET/MRI scan). Improved Sensitivity and Specificity: Radiopharmaceuticals can detect disease at the molecular level, often earlier than anatomical changes appear, while T2MR provides high-resolution structural details.
1 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:27 PM
$TTOO https://www.linkedin.com/posts/-red-_wef26-activity-7420177839939026944-sEcI
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:26 PM
$TTOO https://medicalcountermeasures.gov/barda/dddi
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:25 PM
$TTOO https://nanoporetech.com/news/oxford-nanopore-receives-regulatory-approval-for-its-first-diagnostic-device-in-the-uk-and-europe
0 · Reply
Latest News on TTOO
No data available.
Fair_Trader42
Fair_Trader42 Jan. 25 at 4:43 AM
$TTOO This new Sepsis Care Act.. The Act’s focus on standardizing sepsis care and incentivizing performance improvements will push hospitals toward technologies that reduce time to diagnosis and improve outcomes. As hospitals are measured and potentially rewarded on sepsis outcomes, technologies that shift antibiotic therapy and more accurately will become more attractive. They reward performance, and rapid diagnostics meet those metrics. The Act creates system-level incentives where T2Dx excels. The $20 million is a policy lever that: • pushes hospitals to prioritize quality sepsis care, • encourages adoption of better diagnostics, and • strengthens the climate for technologies like T2Dx. In other words: this is a direct and meaningful tailwind for the clinical adoption thesis around rapid sepsis diagnostics!
0 · Reply
bud1234
bud1234 Jan. 25 at 1:38 AM
$TTOO why did t2 biosystems name their technology T2MR when radiology already has a MRI Scanner that is referenced as T2MR? T2 Biosystems named their technology T2MR because the term is a precise technical description of the specific physical principle their device measures: the T2 relaxation time of water molecules in a magnetic field. The overlap with the radiology term "T2MR" (referring to T2-weighted MRI) is due to both technologies being based on the exact same underlying physics principle, but applied in different contexts. The Rationale for the Name Shared Scientific Principle: Both the T2 Biosystems instrument and a conventional MRI scanner operate using magnetic resonance technology. They both rely on measuring how hydrogen protons in water molecules react in the presence of a magnetic field and the subsequent signal they produce as they "relax".
1 · Reply
bud1234
bud1234 Jan. 25 at 1:17 AM
$TTOO Correction... again apologizes... can radiopharmaceuticals assist T2Dx instrument in diagnostics No, radiopharmaceuticals do not assist the T2Dx® Instrument in diagnostics; the two technologies operate on entirely separate physical and biological principles and are used in different diagnostic fields. Radiopharmaceuticals vs. the T2Dx Instrument Radiopharmaceuticals are used for in vivo imaging (inside the body) via nuclear medicine scans (PET or SPECT). They detect metabolic or functional activity by emitting radiation, which the scanner captures to create an image of the body. The T2Dx Instrument is an in vitro laboratory diagnostic device. It analyzes a patient's whole blood sample using T2 magnetic resonance (T2MR) technology to rapidly detect the DNA of specific sepsis-causing pathogens (bacteria and fungi).
0 · Reply
bud1234
bud1234 Jan. 25 at 1:01 AM
$TTOO please note T2MR referenced in my post below is not connected to T2 Biosystems. .. a T2MR scanner is not the same as the T2MR instrument that test blood for sepsis? A large whole-body T2MR scanner is used in radiology for anatomical imaging apologize for the misunderstanding and mis direction..
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 25 at 12:10 AM
$TTOO https://www.sepsis.org/news/sepsis-alliance-congratulates-house-leaders-on-introduction-of-the-sepsis-act/
0 · Reply
bud1234
bud1234 Jan. 24 at 9:38 PM
$TTOO Jan 23 2026 Seeking Alpha article: CAH Position In Radiopharmaceuticals https://seekingalpha.com/article/4862216-cardinal-health-upgraded-maintains-investment-grade-status-and-positioning-in-radiopharmaceuticals
1 · Reply
bud1234
bud1234 Jan. 24 at 9:32 PM
$TTOO ai info, DD req'd ( AI can make mistakes so verify) Possible future CAH/ T2MR Technology collaboration?? Cardinal Health has spent more than $50 million in the past three years on the plant, named the Center for Theranostics (a combination of “therapeutics” and “diagnostics”) Radiopharmaceuticals work with T2 Magnetic Resonance (T2MR) diagnostics by offering functional/molecular information via nuclear imaging (PET or SPECT), which is then combined with the anatomical/structural details and T2 relaxation data from an MRI to provide a more complete clinical picture. This integrated approach is often referred to as theranostics or hybrid imaging (e.g., a PET/MRI scan). Improved Sensitivity and Specificity: Radiopharmaceuticals can detect disease at the molecular level, often earlier than anatomical changes appear, while T2MR provides high-resolution structural details.
1 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:27 PM
$TTOO https://www.linkedin.com/posts/-red-_wef26-activity-7420177839939026944-sEcI
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:26 PM
$TTOO https://medicalcountermeasures.gov/barda/dddi
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 9:25 PM
$TTOO https://nanoporetech.com/news/oxford-nanopore-receives-regulatory-approval-for-its-first-diagnostic-device-in-the-uk-and-europe
0 · Reply
bud1234
bud1234 Jan. 24 at 9:17 PM
$TTOO AI info Your DD required to verify. continuation: (T2MR) imaging provides high-resolution anatomical details through a combination of inherent MRI capabilities, optimized pulse sequences, and advanced hardware. When these detailed structural images are fused from radiopharmaceuticals, physicians can precisely localize abnormal activity. Assisting Precise Localization through Fusion The high-resolution T2MR structural data provides the essential anatomical map onto which the functional data from radiopharmaceuticals is overlaid. Anatomical Context: The radiopharmaceutical scan (PET or SPECT) provides "metabolic" information, showing where a specific biological process is highly active (e.g., a tumor with high glucose uptake). However, functional images alone often have limited spatial resolution and lack precise anatomical landmarks. The T2MR image provides the clear, detailed anatomical context necessary to determine the exact location and physical extent of that "hot spot".
1 · Reply
Zefram
Zefram Jan. 24 at 7:41 PM
$TTOO now you know how i feel interacting with you guys... minus the you being right at anything.. but can you imagine explaining how everything works to people and telegraphing exactly how things would turn out and they're still losing like imbeciles? welcome to my world...
0 · Reply
Cheeseburgermoney
Cheeseburgermoney Jan. 24 at 5:40 PM
$TTOO
2 · Reply
LicketySplitz03
LicketySplitz03 Jan. 24 at 3:49 PM
$TTOO 😎⏰💰💰💰
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 23 at 11:53 PM
$TTOO https://newsroom.cardinalhealth.com/Highlighting-Strategic-Progress-in-Fiscal-Year-2026-at-the-J-P-Morgan-Healthcare-Conference
2 · Reply
LicketySplitz03
LicketySplitz03 Jan. 23 at 11:38 PM
$TTOO https://www.linkedin.com/posts/abhishek-sable-54a092222_moleculardiagnostics-ivd-companiondiagnostics-activity-7419416010421833728-ejkx
0 · Reply
Joe32141
Joe32141 Jan. 23 at 9:21 PM
$TTOO
0 · Reply
bud1234
bud1234 Jan. 23 at 9:15 PM
$TTOO
0 · Reply
tcamp923
tcamp923 Jan. 23 at 9:13 PM
$TTOO Jesus Christ you all are exhausting
1 · Reply
LicketySplitz03
LicketySplitz03 Jan. 23 at 4:22 PM
$TTOO https://www.linkedin.com/posts/nanda-kishore-22180159_antimicrobialresistance-amr-antibioticresistance-activity-7418313677067476992-U9Z7
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 23 at 4:12 PM
$TTOO https://www.linkedin.com/posts/tamrisa_tamrisa-receives-gardp-support-for-tmr010-activity-7420010252139405312-vJtg
0 · Reply
LicketySplitz03
LicketySplitz03 Jan. 23 at 4:11 PM
$TTOO https://www.linkedin.com/posts/kudzai-mkwakwami-2340b6103_antimicrobialstewardship-amr-patientsafety-activity-7420099282931777536-yeDS
0 · Reply